International brokerage firm UBS downgraded BHEL to "Neutral" from "Buy" rating, while raising its target price to Rs 460 from Rs 375, indicating a potential upside of 13.6%. In today’s session, the stock is up over 1% at Rs 411 on the BSE.
UBS believes a significant portion of the company's order book expansion is already behind it and noted that competition has intensified over the last three years, with rivals such as L&T and Thermax displaying a stronger appetite for new orders. The brokerage said the stock's risk-reward profile has become more balanced after BHEL outperformed the Nifty by nearly 60% over the past 12 months.
